This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry
by Debanjana Dey
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
Best Growth Stocks to Buy for April 9th
by Zacks Equity Research
PBI, MPTI and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 9, 2025
Ensign Group Invests in Growth With New Facility Acquisitions
by Zacks Equity Research
ENSG continues its strategic growth with new acquisitions across Washington and California.
Best Growth Stocks to Buy for April 3rd
by Zacks Equity Research
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 3, 2025.
Best Growth Stocks to Buy for April 1st
by Zacks Equity Research
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 1, 2025.
Centene & HMHB Hawaii Expand Partnership for Maternal Care
by Zacks Equity Research
CNC's Ohana Health Plan and HMHB Hawaii expand maternal care, enhancing support for mothers and babies through strategic investment and community partnerships.
Option Care Health, Inc. (OPCH) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Option Care (OPCH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons Growth Investors Will Love Option Care (OPCH)
by Zacks Equity Research
Option Care (OPCH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
OPCH vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
OPCH vs. CHE: Which Stock Is the Better Value Option?
Centene's Meridian Unit Secures a D-SNP Contract in Illinois
by Zacks Equity Research
CNC's Meridian Health Plan wins a D-SNP contract in Illinois, expanding enhanced managed care for Medicare-Medicaid-eligible individuals. The deal is likely to boost Centene's foothold and membership base in the state.